← Back to Patent Explorer
US4459227A Expired / Lapsed US ⏱️ 0.0 years remaining

Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones

Assignee: Duke University
•
Filing: 1981-03-02
•
Granted: 1984-07-10
•
Expires: 2001-03-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Iminoquinone precursors having the formula ##STR1## wherein R 1 represents hydrogen or an enzymatically hydrolyzable group; R 2 and R 3 independently represent hydrogen, a non-electron-withdrawing organic substituent or an enzymatically hydrolyzable group except that when R 1 is hydrogen, R 2 must be an enzymatically hydrolyzable group and R 3 must not inhibit the hydrolysis of R 2 ; R 4 represents hydrogen or an electron-withdrawing or non-electron-withdrawing organic substituent, except that if R 1 is hydrogen, R 4 may not inhibit the hydrolysis of R 2 ; W, X, Y and Z independently represent hydrogen or an electron-withdrawing or non-electron-withdrawing organic substituent, or any one of X and W, Y and Z, or X and R 4 taken together represents a cyclic or heterocyclic ring having 5 to 6 ring atoms; and wherein said enzymatically hydrolyzable group is selected so that a hydrolysis product is biologically benign for the biological system in which said precursor is present is produced by hydrolysis of the hydrolyzable group. Also disclosed are methods of synthesis and methods of use of these compounds.

Inventors

  • 👤 Reinhardt O. Sahmel
  • 👤 Doyle G. Graham

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 06:56
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 267 words
Iminoquinone precursors having the formula: ##STR12## wherein (1) R 1 is hydrogen; phosphate; pyrophosphate; glycosyl; ribosyl; C 1 -C 30 acyl or arylacyl wherein said acyl or arylacyl is attached to the remainder of said formula by a --CO-- group; deoxyribosyl; aminoacyl having the formula --COCHR 5 NH 2 where R 5 is selected from the group consisting of side chains present in naturally occurring amino acids; bovine serum albumin; or sulfate; (2) R 2 and R 3 independently represent R 1 , alkyl, aryl, or arylalkyl; (3) R 4 is R 2 , halogen, cyano, a radical of the formula ##STR13## wherein (a) R 5 is selected from the group consisting of side chains present in naturally occurring amino acids and (b) R 6 represents hydroxy; alkoxy; --O - M + where M + represents a singly charged metal ion; bovine serum albumin; or ##STR14## a radical of the formula ##STR15## where R 5 and R 6 have the meanings previously defined; (4) O represents oxygen or --NH--; and (5) W, X, Y and Z independently represent hydrogen, halogen, hydroxy, alkoxy, aryloxy, alkylthio, amino, carboxyl, formyl, alkylamino, dialkylamino, acylamino, cyano, or nitro, or X and W or Y and Z taken together represents a carbocyclic ring having 5 to 6 ring atoms; (6) with the provisos that at least one of R 1 or R 2 must be an enzymatically hydrolyzable phosphate, pyrophosphate, glycosyl, ribosyl, deoxyribosyl, acyl, arylacyl, aminoacyl, bovine serum albumin, or sulfate group and when R 1 is hydrogen, neither R 3 nor R 4 may inhibit the enzymatic hydrolysis of R 2 .
Claim 2
Dependent Claim 267 words
Iminoquinone precursors having the formula: ##STR12## wherein (1) R 1 is hydrogen; phosphate; pyrophosphate; glycosyl; ribosyl; C 1 -C 30 acyl or arylacyl wherein said acyl or arylacyl is attached to the remainder of said formula by a --CO-- group; deoxyribosyl; aminoacyl having the formula --COCHR 5 NH 2 where R 5 is selected from the group consisting of side chains present in naturally occurring amino acids; bovine serum albumin; or sulfate; (2) R 2 and R 3 independently represent R 1 , alkyl, aryl, or arylalkyl; (3) R 4 is R 2 , halogen, cyano, a radical of the formula ##STR13## wherein (a) R 5 is selected from the group consisting of side chains present in naturally occurring amino acids and (b) R 6 represents hydroxy; alkoxy; --O - M + where M + represents a singly charged metal ion; bovine serum albumin; or ##STR14## a radical of the formula ##STR15## where R 5 and R 6 have the meanings previously defined; (4) O represents oxygen or --NH--; and (5) W, X, Y and Z independently represent hydrogen, halogen, hydroxy, alkoxy, aryloxy, alkylthio, amino, carboxyl, formyl, alkylamino, dialkylamino, acylamino, cyano, or nitro, or X and W or Y and Z taken together represents a carbocyclic ring having 5 to 6 ring atoms; (6) with the provisos that at least one of R 1 or R 2 must be an enzymatically hydrolyzable phosphate, pyrophosphate, glycosyl, ribosyl, deoxyribosyl, acyl, arylacyl, aminoacyl, bovine serum albumin, or sulfate group and when R 1 is hydrogen, neither R 3 nor R 4 may inhibit the enzymatic hydrolysis of R 2 .
Claim 3
Dependent Claim 32 words
The iminoquinone precursors of claim 1, wherein R 1 is hydrogen; R 2 is acyl, arylacyl, aminoacyl or phosphate; R 3 is hydrogen; and R 4 is --CHR 5 COR 6 .
Claim 4
Dependent Claim 11 words
The iminoquinone precursors of claim 2, wherein R 2 is aminoacyl.
Claim 5
Dependent Claim 29 words
The iminoquinone precursors of claim 3, wherein R 2 is ##STR16## where R 5 is selected from the group consisting of side chains present in naturally occurring amino acids.
Claim 6
Dependent Claim 31 words
The iminoquinone precursors of claim 4, wherein R 6 represents hydroxy, alkoxy having 1-5 carbon atoms, or --O - M + where M + represents a singly charged alkali metal ion.
Claim 7
Dependent Claim 11 words
The iminoquinone precursors of claim 5, wherein R 5 is hydrogen.
Claim 8
Dependent Claim 11 words
The iminoquinone precursors of claim 6, which is β-N-(L-leucyl)-α-N-(carboxymethyl ethyl ester)-p-hydroxyphenylhydrazine.
Claim 9
Dependent Claim 11 words
The iminoquinone precursors of claim 6, which is β-N-(L-phenylalanyl)-β-N-(carboxymethyl ethyl ester)-p-hydroxyphenylhydrazine.
Claim 10
Dependent Claim 11 words
The iminoquinone precursors of claim 6, which is β-N-(L-alanyl)-α-N-(carboxymethyl ethyl ester)-p-hydroxyphenylhydrazine.
Claim 11
Dependent Claim 11 words
The iminoquinone precursors of claim 6, which is β-N-(L-lysyl)-α-N-carboxymethyl ethyl ester)-p-hydroxyphenylhydrazine.
Claim 12
Dependent Claim 11 words
The iminoquinone precursors of claim 6, which is β-N-(L-glutamyl)-α-N-carboxymethyl ethyl ester)-p-hydroxyphenylhydrazine.
Claim 13
Dependent Claim 23 words
The iminoquinone precursors of claim 4, having the formula ##STR17## wherein Prot represents bovine serum albumin and t is from 1 to 500.
Claim 14
Dependent Claim 19 words
The iminoquinone precursors of claim 12, wherein Prot represent bovine serum albumin and t is from 1 to 120.
Claim 15
Dependent Claim 17 words
The iminoquinone precursors of claim 13, wherein R 5 is (CH 3 ) 2 CHCH 2 --.
Claim 16
Dependent Claim 27 words
A method of forming an iminoquinone in situ in a biological system, comprising administering a compound as described in claim 1, 2 or 4 to an organism.
Claim 17
Dependent Claim 21 words
The method of claim 15, wherein said organism is a unicellular organism or a yeast and said administering is by contact.
Claim 18
Dependent Claim 20 words
The method of claim 15, wherein said organism is a multi-cellular organism and administering is by contact, injection or ingestion.
Claim 19
Dependent Claim 30 words
The method of claim 17, wherein said iminoquinone is selectively formed in a first cell or tissue in the presence of a second cell or tissue in a multi-cellular organism.
Claim 20
Dependent Claim 17 words
The method of claim 15, wherein said administering is in the presence of a suitable pharmaceutical carrier.
Claim 21
Dependent Claim 17 words
The method of claim 17, wherein said administering is in the presence of a suitable pharmaceutical carrier.

References Cited (Backward Citations)

US2995567A Cited
US3419659A Cited
US3884919A Cited
US3931222A Cited
US4207338A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-07-10 1988-01-09 1988-07-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-07-10 1992-01-09 1992-07-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-07-10 1996-01-09 1996-07-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag